Rare diseases
Investigational molecules
Locations
Geissweg 3, Innenstadt, 72076 Tuebingen, Germany
Clinical research includes acute myeloid leukemia, myelodysplastic neoplasms, chronic lymphocytic leukemia, lymphoma, and acute lymphoblastic leukemia, with activity across relapsed, refractory, and post-transplant settings.
Research also covers fusion-driven sarcomas, fibrolamellar hepatocellular carcinoma, and immunotherapy-based approaches in advanced blood cancers and solid tumors.
Universitaetsklinikum Tuebingen AöR runs clinical trials in conditions such as Parkinson's disease, Acute myeloid leukaemia, Acute lymphocytic leukaemia, Retinopathy of prematurity, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyEfficacy of intravenous prasinezumab versus placebo in Parkinson's disease patients with severe GBA mutation: a 104‑week randomized double‑blind study
FranceStudy of venetoclax, treosulfan and fludarabine before stem cell transplant in patients with acute myeloid leukemia and myelodysplastic syndrome
GermanyStudy of intestinal gel containing levodopa, carbidopa and entacapone to treat motor and behavioral symptoms in patients with Parkinson's disease
GermanyStudy on MB-CART2219.1 for Adults and Children with Relapsed or Refractory B-cell Malignancies
GermanyStudy of DNAJB1-PRKACA Peptide Vaccine for Patients with Fibrolamellar Hepatocellular Carcinoma and Other Tumors with Oncogenic Driver Fusion
GermanyStudy on the Safety and Effectiveness of Tafasitamab for Children with Relapsed or Refractory Acute B Lineage Leukemia
GermanyStudy on Early Detection of Side Effects in Metastatic Melanoma Patients Using Zirconium (89Zr) Crefmirlimab Berdoxam Imaging
GermanyStudy on Ketamine and CBASP for Treating Chronic Depression in Adults
GermanyStudy of Nivolumab for Patients with Metastatic Solid Tumors and Leptomeningeal Disease
GermanyStudy of Venetoclax and Decitabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
GermanyStudy on Dapagliflozin and Lifestyle Changes for Patients with Early Chronic Kidney Disease and Prediabetes
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
